Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

TBPHTBPH
Showing 7 of 17 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in THERAVANCE BIOPHARMA INC

Janus Henderson Group Ltd. holds 378,978 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $6.2M as of 2026-Q1. The position was decreased (-5.4% shares). TBPH represents 0.0% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$6.2M

Current Shares

378,978

Total Value Change

+$5.9M

Total Shares Change

+354,312

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
378,978
-5.4%
$6.2M0.0%$13.96
0
2025-Q4
Increased
400,496
+214.8%
$7.5M0.0%$18.91
44
2025-Q3
New
127,208
-
$1.9M0.0%$14.43
36
2025-Q1
Exited
0
-100.0%
$00.0%$9.23
0
2024-Q4
Unchanged
24,666
0.0%
$232,3540.0%$9.47
0
2024-Q3
Unchanged
24,666
0.0%
$199,0550.0%$8.10
0
2024-Q2
Decreased
24,666
-0.9%
$208,9210.0%$8.48
0

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used